• Ajay Kumar
• Pooja Rao
• Ankita Raikwar

Review includes PvPI(Pharmacovigilance Programme of India) illustration that is used to protect the population's health particularly in India by ensuring advantages of using a medicine that outweighs any hazards. Significant social and economic costs associated with adverse drug reactions and favourable benefit-to-cost ratio of implementing appropriate risk management, it is necessary to involve both the general public and healthcare professionals in a well-organized programme to create synergies for tracking adverse drug reactions across the nation. This review basically involves discussion and analysis about current situation and future of PV(Pharmacovigilance) in India as well as globally. Pharmacovigilance legislation aims to reduce number of Adverse Reactions (ADRs) and is achieved by collection of better data on medicines and their safety. Rapid and robust assessment of issues related to safety of medicines, effective regulatory action to deliver safe and effective use of medicines, empowerment of patients through reporting and participation, increased levels of transparency and better communication aims to strengthen the Pharmacovigilance status in India.

Pharmacovigilance, Adverse drug reaction, PvPI, EU, MHRA.

"A REVIEW ON NATIONAL & INTERNATIONAL SCENARIO OF PHARMACOVIGILANCE", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 5, page no.d547-d555, May-2024, Available :http://www.jetir.org/papers/JETIR2405361.pdf

"A REVIEW ON NATIONAL & INTERNATIONAL SCENARIO OF PHARMACOVIGILANCE", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 5, page no. ppd547-d555, May-2024, Available at : http://www.jetir.org/papers/JETIR2405361.pdf